Showing posts with label Bribery. Show all posts
Showing posts with label Bribery. Show all posts

Saturday, 6 April 2013

When Life Tumbles In, What Then?

Ray Pritchard

Job 1

When his wife died, he didn’t know at first how he would survive. Although he was a minister and had helped many others through times of crisis, now he faced his own personal moment of truth. How would he reconcile his own loss with the Christian faith he claimed to believe? What would he say to his own grieving congregation?

The year was 1927. The place, Aberdeen, Scotland. The man, Arthur John Gossip, pastor of the Beechgrove Church. He was fifty-four years old and at the height of his powers.

Historians tell us that he was humble and sincere, possessing a keen wit and deeply devoted to his family and friends. A bit of an eccentric, he sometimes scandalized his staid Scottish congregation by appearing in public with a floppy fisherman’s hat perched on his head. He was a man of strong opinions who never held back from expressing them to any and all who cared to listen. History also tells us that he was beloved as a pastor and preacher.

Wednesday, 13 March 2013

Doctors Paid Millions to Shill for Big Pharma


How the pharmaceutical industry bribes medical professionals.


  
Update Mar. 11, 2013, 4:55 pm: This post has been updated to reflect a response by Dr. Vladimir Maletic to questions from ProPublica.
Dr. Jon W. Draud, the medical director of psychiatric and addiction medicine at two Tennessee hospitals, pursues some eclectic passions. He’s bred sleek Basenji hunting dogs for show. And last summer, the Tennessee State Museum featured “African Art: The Collection of Jon Draud.”
But the Nashville psychiatrist is also notable for a professional pursuit: During the last four years, the 47-year-old Draud  has earned more than $1 million for delivering promotional talks and consulting for seven drug companies.
By a wide margin, Draud’s earnings make him the best-paid speaker in ProPublica’s Dollars for Docs database, which has been updated to include more than $2 billion in payments from 15 drugmakers for promotional speaking, research, consulting, travel, meals and related expenses from 2009 to 2012.